Dexmedetomidine

Generic Name
Dexmedetomidine
Brand Names
Dexdor, Igalmi, Precedex, Dexmedetomidine Accord
Drug Type
Small Molecule
Chemical Formula
C13H16N2
CAS Number
113775-47-6
Unique Ingredient Identifier
67VB76HONO
Background

An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.

Indication

Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.

Associated Conditions
Agitation, Alcohol Withdrawal Syndrome
Associated Therapies
-

Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass

First Posted Date
2022-10-28
Last Posted Date
2024-03-21
Lead Sponsor
Affiliated Hospital of Nantong University
Target Recruit Count
64
Registration Number
NCT05598177
Locations
🇨🇳

Affiliated Hospital Nantong University, Nantong, Jiangsu, China

The Effect of Intraperitoneal Injection of Magnesium Sulphate Versus Dexmedetomidine as an Adjuvant to Bupivacaine on Postoperative Analgesia in Patients Undergoing Abdominal Aortic Surgery

First Posted Date
2022-10-13
Last Posted Date
2022-10-13
Lead Sponsor
Mansoura University
Target Recruit Count
50
Registration Number
NCT05577260
Locations
🇪🇬

Mansoura University,Mansoura University Hospitals, Mansoura, Dakahlia, Egypt

Dexmedetomidine in Off Pump Coronary Artery Bypass Grafting

Not Applicable
Not yet recruiting
Conditions
Interventions
First Posted Date
2022-10-13
Last Posted Date
2022-10-13
Lead Sponsor
Suez Canal University
Target Recruit Count
36
Registration Number
NCT05577871

Fentanyl vs Dexmedetomidine for Arthriscopic Shoulder Intervention in Elderly.

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2022-10-13
Last Posted Date
2022-11-21
Lead Sponsor
Cairo University
Target Recruit Count
36
Registration Number
NCT05577117
Locations
🇪🇬

Faculty of medicine Cairo university, Cairo, Egypt

Comparison of the Effects of Remifentanil and Dexmedetomidine Administered Under General Anesthesia in Rhinoplasty

First Posted Date
2022-10-10
Last Posted Date
2022-10-10
Lead Sponsor
Baskent University
Target Recruit Count
50
Registration Number
NCT05572723
Locations
🇹🇷

Baskent University Medical School, Ankara, Turkey

Safety Study of Dexmedetomidine in Elderly Under General Anesthesia

First Posted Date
2022-10-05
Last Posted Date
2022-10-13
Lead Sponsor
Zhenjiang First People's Hospital
Target Recruit Count
200
Registration Number
NCT05567523
Locations
🇨🇳

Zhenjiang First People's Hospital, Zhenjiang, Jiangsu, China

Dexmedetomidine and Magnesium Sulfate in Preventing Junctional Ectopic Tachycardia After Pediatric Cardiac Surgery

First Posted Date
2022-09-26
Last Posted Date
2024-04-18
Lead Sponsor
Kasr El Aini Hospital
Target Recruit Count
120
Registration Number
NCT05554848
Locations
🇪🇬

Kasralainy Faculty of Medicine, Cairo, Egypt

The Application and Validation of Triple Drug Response Surface Models on Density Spectral Array in Clinical Anesthesia

First Posted Date
2022-09-01
Last Posted Date
2022-09-07
Lead Sponsor
Taipei Veterans General Hospital, Taiwan
Target Recruit Count
60
Registration Number
NCT05525351
Locations
🇨🇳

Taipei Veterans General Hospital, Taipei, Taiwan

In Vitro Evaluation of Spontaneous and Oxytocin-induced Contractility of Pregnant Human Myometrium During Exposure to Dexmedetomidine

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2022-08-23
Last Posted Date
2024-02-26
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
28
Registration Number
NCT05511415
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

The Effects of Sedatives on Tobacco Use Disorder Version 2

First Posted Date
2022-08-18
Last Posted Date
2024-07-08
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
52
Registration Number
NCT05505630
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath